|
|
Volumn 344, Issue 7854, 2012, Pages
|
|
What can we learn from asthma in elite athletes?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALLERGEN;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BRONCHODILATING AGENT;
CORTICOSTEROID;
CROMOGLYCATE DISODIUM;
FORMOTEROL;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
LONG ACTING DRUG;
SALBUTAMOL;
SALMETEROL;
SHORT ACTING DRUG;
ASTHMA;
ATHLETE;
ATHLETIC PERFORMANCE;
BRONCHOSPASM;
COLD AIR;
DIAGNOSTIC ERROR;
DISEASE CONTROL;
DISEASE COURSE;
DISEASE EXACERBATION;
DISEASE PREDISPOSITION;
DRUG CONTROL;
DRUG MISUSE;
DRUG USE;
ENDURANCE TRAINING;
ENVIRONMENTAL EXPOSURE;
ETHNIC DIFFERENCE;
EXERCISE;
EXERCISE INDUCED ASTHMA;
HUMAN;
INHALER;
LUNG DISEASE;
LUNG VENTILATION;
MEDICAL SOCIETY;
MONOTHERAPY;
POLLUTION;
POPULATION RESEARCH;
PREVALENCE;
PRIORITY JOURNAL;
PROFESSIONAL DELEGATION;
PUBLIC HEALTH PROBLEM;
REVIEW;
SWIMMING POOL;
SYMPTOMATOLOGY;
THERAPY EFFECT;
TREATMENT RESPONSE;
ADRENERGIC BETA-2 RECEPTOR AGONISTS;
ANTI-ASTHMATIC AGENTS;
ASTHMA;
ASTHMA, EXERCISE-INDUCED;
ATHLETES;
HUMANS;
SPORTS MEDICINE;
|
|
EID: 84860321270
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.e2556 Document Type: Review |
|
Times cited : (12)
|
|
References (9)
|
